A Win For Karuna Therapeutics, Inc.
Tue, Nov 19, 2019 at 05:30 PM
Karuna Therapeutics, Inc. (KRTX:NASDAQ) rocketted today at $123.99, representing a gain of 29.2%. On Mon, 18 Nov 19, KRTX:NASDAQ hit a New 2-Week High of $96. The stock featured on our News Catalysts scanner on Tue, 19 Nov 19 at 12:07 PM. From Tue, 29 Oct 19, the stock recorded 71.43% Up Days and 60.00% Green Days
About Karuna Therapeutics, Inc. (KRTX:NASDAQ)
Karuna Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Top 10 Gainers:
- Myovant Sciences Ltd. (MYOV:NYSE), 113.2%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 80.92%
- Genprex, Inc. (GNPX:NASDAQ), 48.93%
- Athenex, Inc. (ATNX:NASDAQ), 35.66%
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 29.2%
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 29.16%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 28.43%
- Heat Biologics, Inc. (HTBX:NASDAQ), 26.22%
- Avinger, Inc. (AVGR:NASDAQ), 25.49%
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 25.03%